“…The latter concept has been challenged by growing evidence showing low-grade inflammatory changes in the gut and altered gut-brain axis signaling. 1,2 According to the Rome III classification, FBDs include the irritable bowel syndrome (IBS), functional bloating (FB), functional constipation, functional diarrhea, and unspecified FBD, and they are attributed to abnormalities likely originating from the small bowel, colon, and rectum. 3,4 Since FBDs lack objective biomarkers, their diagnosis is based on the clinical symptoms reported by patients, physical examination, and the exclusion of alarm symptoms/signs (eg, blood in stools, anemia, weight loss, and others).…”